Rigel Pharmaceuticals Inc (RIGL)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
Apr 24, 16:00
1.13
0.00 (0.00%)
After-Hours: 18:12
Rigel Pharmaceuticals Market Cap: 198.18M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 199.93M |
| April 22, 2024 | 198.18M |
| April 19, 2024 | 189.41M |
| April 18, 2024 | 184.15M |
| April 17, 2024 | 194.67M |
| April 16, 2024 | 199.93M |
| April 15, 2024 | 201.68M |
| April 12, 2024 | 210.45M |
| April 11, 2024 | 215.71M |
| April 10, 2024 | 213.96M |
| April 09, 2024 | 219.22M |
| April 08, 2024 | 220.98M |
| April 05, 2024 | 226.24M |
| April 04, 2024 | 226.24M |
| April 03, 2024 | 233.25M |
| April 02, 2024 | 233.25M |
| April 01, 2024 | 235.01M |
| March 28, 2024 | 259.56M |
| March 27, 2024 | 261.31M |
| March 26, 2024 | 249.04M |
| March 25, 2024 | 252.54M |
| March 22, 2024 | 249.04M |
| March 21, 2024 | 254.30M |
| March 20, 2024 | 249.04M |
| March 19, 2024 | 240.27M |
| Date | Value |
|---|---|
| March 18, 2024 | 235.01M |
| March 15, 2024 | 238.51M |
| March 14, 2024 | 233.25M |
| March 13, 2024 | 254.30M |
| March 12, 2024 | 261.31M |
| March 11, 2024 | 264.82M |
| March 08, 2024 | 275.34M |
| March 07, 2024 | 268.33M |
| March 06, 2024 | 273.59M |
| March 05, 2024 | 259.56M |
| March 04, 2024 | 257.81M |
| March 01, 2024 | 271.84M |
| February 29, 2024 | 266.57M |
| February 28, 2024 | 271.84M |
| February 27, 2024 | 262.24M |
| February 26, 2024 | 248.25M |
| February 23, 2024 | 230.77M |
| February 22, 2024 | 227.27M |
| February 21, 2024 | 195.80M |
| February 20, 2024 | 199.30M |
| February 16, 2024 | 204.55M |
| February 15, 2024 | 213.29M |
| February 14, 2024 | 206.29M |
| February 13, 2024 | 195.80M |
| February 12, 2024 | 211.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
115.77M
Minimum
Jun 10 2022
835.45M
Maximum
Feb 08 2021
371.20M
Average
342.75M
Median
May 22 2019
Market Cap Benchmarks
| Nektar Therapeutics | 256.15M |
| Avid Bioservices Inc | 431.29M |
| Stereotaxis Inc | 196.29M |
| Cara Therapeutics Inc | 37.04M |
| Blueprint Medicines Corp | 5.654B |
Market Cap Related Metrics
| PS Ratio | 1.682 |
| Price | 1.13 |
| Earnings Yield | -12.39% |